In a recent study, Ceci et al. reported that EA reduced the invasive nature of bladder cancer through VEGF-mediated pathways by testing EA against four different human bladder cancer cell lines (T24, UM-UC-3, 5637 and HT-1376) [68]. The gene discussed is VEGFA; the disease is urinary bladder carcinoma.